Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy

Min, Sang-Won, Cho, Seo-Hyun, Zhou, Yungui, Schroeder, Sebastian, Haroutunian, Vahram, Seeley, William W., Huang, Eric J., Shen, Yong +6 more·2010·Neuron
DOI 10.1016/j.neuron.2010.08.044

Cited by (959)

Items 501–600 of 959

  1. Brain microRNAs dysregulation: Implication for missplicing and abnormal post-translational modifications of tau protein in Alzheimer’s disease and related tauopathies
    Maryam Bazrgar, Pariya Khodabakhsh, Fatemeh Mohagheghi, Mercedes Prudencio, Abolhassan Ahmadiani · 2020 · Pharmacological Research
  2. Genetic Code Expansion Tools to Study Lysine Acylation
    Petra Neumann‐Staubitz, Michael Lammers, Heinz Neumann · 2021 · Advanced Biology
  3. Advances in Genetics and Epigenetic Alterations in Alzheimer’s Disease: A Notion for Therapeutic Treatment
    Rubén Rabaneda‐Bueno, Beatriz Mena‐Montes, Sara Torres‐Castro, Norma Torres‐Carrillo, Nora Magdalena Torres-Carrillo · 2021 · Genes
  4. Patchouli alcohol ameliorates the learning and memory impairments in an animal model of Alzheimer's disease via modulating SIRT1
    Qingqing Xu, Ziren Su, Zhen Jie Hu, Wen Yang, Yan‐Fang Xian, Zhi‐Xiu Lin · 2022 · Phytomedicine
  5. Palmitoylation acts as a checkpoint for MAVS aggregation to promote antiviral innate immune responses
    Liqiu Wang, Mengqiu Li, Guang‐Yu Lian, Shuai Yang, Jing Cai, Zhe Cai, Yaoxing Wu, Jun Cui · 2024 · Journal of Clinical Investigation
  6. Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activity
    John R. P. Knight, Simon J. Allison, Jo Milner · 2013 · Open Biology
  7. Astrogliopathy in Tauopathies
    Isidró Ferrer · 2018 · Neuroglia
  8. Cellular Biology of Tau Diversity and Pathogenic Conformers
    Sang‐Gyun Kang, Ghazaleh Eskandari‐Sedighi, Lenka Hromádková, Jiri Safar, David A. Westaway · 2020 · Frontiers in Neurology
  9. A Distinct Tau Code Controlled by HDAC6 is Linked to Tau Pathogenesis and the Neuronal Stress Response
    Jui‐Heng Tseng, Aditi Ajit, Zarin Tabassum, Niyati Patel, Xu Tian, Youjun Chen, Alex W. Prevatte, Karen Ling, Frank Rigo, Rick B. Meeker et al. · 2020 · Cell Reports
  10. Sirtuin Oxidative Post-translational Modifications
    Kelsey Kalous, Sarah L. Wynia‐Smith, Brian C. Smith · 2021 · Frontiers in Physiology
  11. Screening for Compounds That Modulate Epigenetic Regulation of the Transcriptome: An Overview
    Richard M. Eglen, Terry Reisine · 2011 · SLAS DISCOVERY
  12. The Transcription Factor XBP1 in Memory and Cognition: implications in Alzheimer’s Disease
    Moustapha Cissé, Eric Duplan, Frédéric Checler · 2016 · Molecular Medicine
  13. Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings
    Pallavi Duggal, Sidharth Mehan · 2019 · Journal of Alzheimer s Disease Reports
  14. Quantitating the epigenetic transformation contributing to cholesterol homeostasis using Gaussian process
    Chao Wang, Samantha M. Scott, Kanagaraj Subramanian, Salvatore Loguercio, Pei Zhao, Darren M. Hutt, Nicole Yanjanin Farhat, Forbes D. Porter, William E. Balch · 2019 · Nature Communications
  15. Involvement of chronic unpredictable mild stress-induced hippocampal LRP1 up-regulation in microtubule instability and depressive-like behavior in a depressive-like adult male rat model
    Hui Wang, Ling Xiao, Gaohua Wang, Gaohua Wang · 2019 · Physiology & Behavior
  16. The Acetyl Mimicking Mutation, K274Q in Tau, Enhances the Metal Binding Affinity of Tau and Reduces the Ability of Tau to Protect DNA
    Jitendra Subhash Rane, Anuradha Ranjan Kumari, Dulal Panda · 2019 · ACS Chemical Neuroscience
  17. Acetylation of Aβ42 at Lysine 16 Disrupts Amyloid Formation
    Rashmi Adhikari, Mu Yang, Nabanita Saikia, Colina Dutta, Wafa Fhad A Alharbi, Zhiying Jenny Shan, Ravindra Pandey, Ashutosh Tiwari · 2020 · ACS Chemical Neuroscience
  18. Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280–acetylated tau in cell and mouse models
    Song, Ha-Lim, Kim, Na-Young, Park, Jaewan, Kim, Meong Il, Jeon, Yu-Na, Lee, Se-Jong, Cho, Kwangmin, Shim, Young-Lim, Lee, Kyoung-Hye, Mun, Yeon-Seon et al. · 2023 · Journal of Clinical Investigation
  19. Effect of Exercise and Oral Niacinamide Mononucleotide on Improving Mitochondrial Autophagy in Alzheimer’s Disease
    Weijia Wu, Shunling Yuan, Yingzhe Tang, Xiangyuan Meng, Mei Peng, Zelin Hu, Wenfeng Liu · 2023 · Nutrients
  20. Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry
    Michael J. Ellis, Christiana Lekka, Katie L. Holden, Hanna Tulmin, Faheem Seedat, Darragh Patrick O'Brien, Shalinee Dhayal, Marie‐Louise Zeissler, Jakob Grunnet Knudsen, Benedikt Mathias Kessler et al. · 2024 · Acta Neuropathologica
  21. Post-Translational Modifications in Alzheimer's Disease and the Potential for New Biomarkers
    Claire L. Russell, Saša Končarević, Malcolm Andrew Ward · 2014 · Journal of Alzheimer s Disease
  22. Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
    Cornelius J. H. M. Klemann, Gerard J.M. Martens, Geert Poelmans, Jasper E. Visser · 2015 · Molecular Neurobiology
  23. Mitochondrial Acetylation and Genetic Models of Parkinson's Disease
    Georg W. J. Auburger, Suzana Gispert, Marina Jendrach · 2014 · Progress in molecular biology and translational science
  24. Halting of Caspase Activity Protects Tau from MC1-Conformational Change and Aggregation
    Emma Mead, Dimitra Kestoras, Yolanda Gibson, Lucy Hamilton, Ross J. Goodson, Sophie Jones, Sarah Eversden, Peter Davies, Michael J. O’Neill, Michael L. Hutton et al. · 2016 · Journal of Alzheimer s Disease
  25. Understanding Alzheimer's disease by global quantification of protein phosphorylation and sialylated N-linked glycosylation profiles: A chance for new biomarkers in neuroproteomics?
    Pernille S. Lassen, Camilla Thygesen, Martin R. Larsen, Stefan J. Kempf · 2017 · Journal of Proteomics
  26. Dichotomous Sirtuins: Implications for Drug Discovery in Neurodegenerative and Cardiometabolic Diseases
    Pedro Gomes, Helena Leal, Alexandrina Ferreira Mendes, Flávio Reis, Cláudia Cavadas · 2019 · Trends in Pharmacological Sciences
  27. The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Aggregates
    Benjamin C. Creekmore, Yi‐Wei Chang, Edward B. Lee · 2021 · Journal of Neuropathology & Experimental Neurology
  28. The Structure Biology of Tau and Clue for Aggregation Inhibitor Design
    Dan Wang, Xianlong Huang, Lu Yan, Luo‐Qi Zhou, Yan Chang, Jinhu Wu, Zhengding Su, Yongqi Huang · 2021 · The Protein Journal
  29. SIRT1 deficiency increases O-GlcNAcylation of tau, mediating synaptic tauopathy
    Xiaomin Yin, Yuanyuan Li, Xing Fan, Fang Huang, Yanyan Qiu, Chenhao Zhao, Zheng Zhou, Qun Gu, Liye Xia, Junze Bao et al. · 2022 · Molecular Psychiatry
  30. SIRT1 activation and its circadian clock control: a promising approach against (frailty in) neurodegenerative disorders
    Rodrigo F.N. Ribeiro, Dina Pereira, Luís Pereira de Almeida, Maria Manuel Silva, Cláudia Cavadas · 2022 · Aging Clinical and Experimental Research
  31. Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer’s disease
    Jinhui Hu, Baijiao An, Tingting Pan, Zhengcunxiao Li, Ling Huang, Xingshu Li · 2018 · Bioorganic & Medicinal Chemistry
  32. Oxidative Stress Dysregulates Protein Homeostasis Within the Male Germ Line
    Shenae L. Cafe, Brett Nixon, Matthew D. Dun, Shaun D. Roman, Ilana R. Bernstein, Elizabeth G. Bromfield · 2019 · Antioxidants and Redox Signaling
  33. miR‑149‑5p inhibition reduces Alzheimer's disease β‑amyloid generation in 293/APPsw cells by upregulating H4K16ac via KAT8
    Fuyan Chen, Huifeng Chen, Yujie Jia, Hai Lu, Qiaorui Tan, Xin Zhou · 2020 · Experimental and Therapeutic Medicine
  34. HDAC9‐mediated calmodulin deacetylation induces memory impairment in Alzheimer's disease
    Hailong Zhang, Shufen Hu, Pin Yang, Han-Chun Long, Quanhong Ma, Dong‐Min Yin, Guang‐Yin Xu · 2024 · CNS Neuroscience & Therapeutics
  35. Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
    C Bravo, Karen Krukowski, Sarah Barker, Chao Wang, Yaqiao Li, Li Fan, Edwin Vázquez‐Rosa, Min‐Kyoo Shin, Man Ying Wong, Louise D. McCullough et al. · 2024 · Molecular Neurodegeneration
  36. Therapeutic and diagnostic challenges for frontotemporal dementia
    Simon Dâ€TMAlton, Jada M. Lewis · 2014 · Frontiers in Aging Neuroscience
  37. Regulatory Effects of Statins on SIRT1 and Other Sirtuins in Cardiovascular Diseases
    Danial Khayatan, Seyed Mehrad Razavi, Zahra Najafi Arab, Maryam Khanahmadi, Saeideh Momtaz, Alexandra E. Butler, Fabrizio Montecucco, Yuliya V. Markina, Amir Hossein Abdolghaffari, Amirhossein Sahebkar · 2022 · Life
  38. Sirtuins and redox signaling interplay in neurogenesis, neurodegenerative diseases, and neural cell reprogramming
    Elisabetta Mormone, Eugenio Luigi Iorio, Lucrezia Abate, Carlo Rodolfo · 2023 · Frontiers in Neuroscience
  39. Disease-associated patterns of acetylation stabilize tau fibril formation
    Li, Li, Nguyen, Binh A., Mullapudi, Vishruth, Li, Yang, Saelices, Lorena, Joachimiak, Lukasz A. · 2023 · Structure
  40. Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry
    Andrea Renee Kelley, Stephan B. H. Bach, George L. Perry · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  41. Sirtuins as Modifiers of Huntington's Disease (HD) Pathology
    Sin Hui Neo, Bor Luen Tang · 2017 · Progress in molecular biology and translational science
  42. Sirt1 protects against hippocampal atrophy and its induced cognitive impairment in middle-aged mice
    Zuhao Sun, Shuang Zhao, Xinjun Suo, Yan Dou · 2022 · BMC Neuroscience
  43. Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer’s Disease
    Devyani Bhatnagar, Shreya Ladhe, Dileep Kumar · 2023 · Molecular Neurobiology
  44. Neuroprotective Impact of Linagliptin against Cadmium-Induced Cognitive Impairment and Neuropathological Aberrations: Targeting SIRT1/Nrf2 Axis, Apoptosis, and Autophagy
    Hany H. Arab, Ahmed H. Eid, Shuruq E. Alsufyani, Ahmed M. Ashour, Azza A. K. El‐Sheikh, Hany W. Darwish, Gehan S. Georgy · 2023 · Pharmaceuticals
  45. Sirtuin 3 Mediates Tau Deacetylation
    Shiping Li, Junxiang Yin, Megan Nielsen, Thomas G. Beach, Li Guo, Jiong Shi · 2019 · Journal of Alzheimer s Disease
  46. Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules
    Jennifer N. Rauch, Steven H. Olson, Jason E. Gestwicki · 2016 · Cold Spring Harbor Perspectives in Medicine
  47. The Mechanistic Link Between Tau-Driven Proteotoxic Stress and Cellular Senescence in Alzheimer’s Disease
    Karthikeyan Tangavelou, Kiran Bhaskar · 2024 · International Journal of Molecular Sciences
  48. Microfluidic Mobility Shift Profiling of Lysine Acetyltransferases Enables Screening and Mechanistic Analysis of Cellular Acetylation Inhibitors
    Alexander W. Sorum, Jonathan H. Shrimp, Allison M. Roberts, David C. Montgomery, Neil K. Tiwari, Madhu Lal‐Nag, Anton M. Simeonov, Ajit Jadhav, Jordan L. Meier · 2015 · ACS Chemical Biology
  49. Mechanism by Which Aluminum Regulates the Abnormal Phosphorylation of the Tau Protein in Different Cell Lines
    Baolong Pan, Xiaoting Lu, Xiao Han, Jiaping Huan, Dan Gao, Shuangjie Cui, Xiaofen Ju, Yunwei Zhang, Shimeng Xu, Jing Song et al. · 2021 · ACS Omega
  50. Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma
    Rayane Hedna, Hervé Kovacic, Alessandra Pagano, Vincent Peyrot, Maxime Robin, François Devred, Gilles Breuzard · 2022 · Cancers
  51. Model Hirano Bodies Protect against Tau-Independent and Tau-Dependent Cell Death Initiated by the Amyloid Precursor Protein Intracellular Domain
    Matthew Furgerson, Marcus Fechheimer, Ruth Furukawa · 2012 · PLoS ONE
  52. NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy
    Francesca Rossi, Philippine C. Geiszler, Weina Meng, Matthew R. Barron, Malcolm J. W. Prior, Anna Herd-Smith, Andrea Loreto, Maria Yanez Lopez, Henryk Faas, Marie‐Christine Pardon et al. · 2017 · Behavioural Brain Research
  53. Recent Tau-Targeted Clinical Strategies for the Treatment of Alzheimer's Disease
    Ha E Lee, Dami Lim, Jae Yeol Lee, Sang Min Lim, Ae Nim Pae · 2019 · Future Medicinal Chemistry
  54. Polyamine Dysregulation and Nucleolar Disruption in Alzheimer’s Disease
    Wesley H. Brooks · 2024 · Journal of Alzheimer s Disease
  55. Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease
    Taylor R. Church, Seth S. Margolis · 2025 · Frontiers in Cell and Developmental Biology
  56. β-Caryophyllene attenuates cadmium induced neurotoxicity in rats by modulating different cellular signaling pathways
    İsmail Bolat, Serkan Yıldırım, Yavuz Selim Sağlam, Selim Çomaklı, Samet Tekin, Merve Bolat, Tuba Doğan, Metin Kılıçlıoğlu, Berrah Gözegi̇r · 2025 · NeuroToxicology
  57. Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives
    Mohammed Alrouji, Mohammed S. Alshammari, Tasqeeruddin Syed, Anas Shamsi · 2025 · Antioxidants
  58. MicroRNA cluster miR199a/214 are differentially expressed in female and male rats following nicotine self-administration
    Steven T. Pittenger, Victoria L. Schaal, Dalia Y. Moore, Rahul S. Guda, Sneh Koul, Sowmya V. Yelamanchili, Rick A. Bevins, Gurudutt Pendyala · 2018 · Scientific Reports
  59. Targeting Tau to Treat Clinical Features of Huntington's Disease
    Maria Masnata, Shireen Salem, Aurélie de Rus Jacquet, Mehwish Anwer, Francesca Cicchetti · 2020 · Frontiers in Neurology
  60. Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer’s disease and related tauopathies
    Nikhil Dave, Austin S. Vural, Ignazio Stefano Piras, Wendy Winslow, Likith Surendra, Joanna K. Winstone, Thomas G. Beach, Matthew J. Huentelman, Ramón Velázquez · 2021 · Acta Neuropathologica
  61. Chemical Synthesis of Microtubule-Associated Protein Tau
    Wyatt C. Powell, Ruiheng Jing, Maciej A. A. Walczak · 2023 · Journal of the American Chemical Society
  62. Epigenomics of Alzheimer's Disease
    Ramón Cacabelos, Clara Torrellas, Francisco Javier Lopez-Munoz · 2014 · Journal of Experimental & Clinical Medicine
  63. Methylation Profiling RIN3 and MEF2C Identifies Epigenetic Marks Associated with Sporadic Early Onset Alzheimer’s Disease
    Kirsty A. Boden, Imelda Barber, Naomi S. Clement, Tulsi Patel, Tamar Guetta‐Baranes, Keeley J. Brookes, Sally Chappell, Jim Craigon, Natalie H. Chapman, Kevin Morgan et al. · 2017 · Journal of Alzheimer s Disease Reports
  64. Alterations of sirtuins in mitochondrial cytochrome c-oxidase deficiency
    Arne Björn Potthast, Theresa Heuer, Simone Johanna Warneke, Anibh Martin Das · 2017 · PLoS ONE
  65. Preclinical, phase I, and phase II investigational clinical trials for treatment of progressive supranuclear palsy
    Ali Shoeibi, Nahid Olfati, Irene Litvan · 2018 · Expert Opinion on Investigational Drugs
  66. Pan-HDAC Inhibitors Promote Tau Aggregation by Increasing the Level of Acetylated Tau
    Hyeanjeong Jeong, Seulgi Shin, Jun‐Seok Lee, Soo Hyun Lee, Ja‐Hyun Baik, Sungsu Lim, Yun Kyung Kim · 2019 · International Journal of Molecular Sciences
  67. The Contribution of Epigenetic Inheritance Processes on Age-Related Cognitive Decline and Alzheimer’s Disease
    Aina Bellver‐Sanchís, Mercè Pallàs, Christian Griñán‐Ferré · 2021 · Epigenomes
  68. Altered Proteostasis in Neurodegenerative Tauopathies
    Katerina Papanikolopoulou, Efthimios M. C. Skoulakis · 2020 · Advances in experimental medicine and biology
  69. Chlamydia pneumoniae in Alzheimer's disease pathology
    Lalita Subedi, Bhakta Prasad Gaire, Yosef Koronyo, Maya Koronyo‐Hamaoui, Timothy R. Crother · 2024 · Frontiers in Neuroscience
  70. Chemogenomic analysis reveals key role for lysine acetylation in regulating Arc stability
    Jasmin Lalonde, Surya A. Reis, Sudhir Sivakumaran, Carl S. Holland, Hendrik Wesseling, John F. K. Sauld, Begüm Alural, Wen‐Ning Zhao, Judith A. J. Steen, Stephen J. Haggarty · 2017 · Nature Communications
  71. Directed evolution of a picomolar-affinity, high-specificity antibody targeting phosphorylated tau
    Dan Li, Lei Wang, Brandon F. Maziuk, Xudong Yao, Benjamin L. Wolozin, Yong Ku Cho · 2018 · Journal of Biological Chemistry
  72. The Functional Role of microRNAs in the Pathogenesis of Tauopathy
    Domenico Praticò · 2020 · Cells
  73. Acetylated Ubiquitin Modulates the Catalytic Activity of the E1 Enzyme Uba1
    Rachel E. Lacoursiere, Gary S. Shaw · 2021 · Biochemistry
  74. Metabolic control of the proteotoxic stress response: implications in diabetes mellitus and neurodegenerative disorders
    Kuo‐Hui Su, Chengkai Dai · 2016 · Cellular and Molecular Life Sciences
  75. Insights Into the Therapeutic Potential of SIRT1-modifying Compounds for Alzheimer’s Disease: A Focus on Molecular Mechanisms
    Dhyauldeen Aftan AlHayani, Aziz Kubaev, Subasini Uthirapathy, Viralkumar B. Mandaliya, Suhas Ballal, Rishiv Kalia, Renu Arya, Baneen C. Gabble, Mohammed Qasim Alasheqi, Abed Jawad KADHIM · 2025 · Journal of Molecular Neuroscience
  76. Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer’s Disease
    Mohammad Arastoo, Richard A. Lofthouse, Lewis K. Penny, Charles R. Harrington, Andy Porter, Claude M. Wischik, Soumya Palliyil · 2020 · International Journal of Molecular Sciences
  77. Multifaced role of protein deacetylase sirtuins in neurodegenerative disease
    Rohan V. Gupta, Rashmi K. Ambasta, Pravir Kumar · 2021 · Neuroscience & Biobehavioral Reviews
  78. Hyperglycemic Neurovasculature‐On‐A‐Chip to Study the Effect of SIRT1‐Targeted Therapy for the Type 3 Diabetes “Alzheimer's Disease”
    Minjeong Jang, Nakwon Choi, Hong Nam Kim · 2022 · Advanced Science
  79. Function and regulation of cis P‐tau in the pathogenesis and treatment of conventional and nonconventional tauopathies
    Ruizhi Wang, Kun Ping Lu, Xiao Zhen Zhou · 2023 · Journal of Neurochemistry
  80. Scrapie Infection in Experimental Rodents and SMB-S15 Cells Decreased the Brain Endogenous Levels and Activities of Sirt1
    Jing Wang, Jin Zhang, Qi Shi, Baoyun Zhang, Cao Chen, Lina Chen, Jing Fang Sun, Hui Wang, Kang Xiao, Xiao‐Ping Dong · 2014 · Journal of Molecular Neuroscience
  81. The Study of Posttranslational Modifications of Tau Protein by Nuclear Magnetic Resonance Spectroscopy: Phosphorylation of Tau Protein by ERK2 Recombinant Kinase and Rat Brain Extract, and Acetylation by Recombinant Creb-Binding Protein
    Haoling Qi, Clément Despres, Sudhakaran Prabakaran, François‐Xavier Cantrelle, Béatrice Chambraud, Jeremy Gunawardena, Guy M. Lippens, Caroline Smet‐Nocca, Isabelle Landrieu · 2016 · Methods in molecular biology
  82. p300-mediated acetylation increased the protein stability of HIPK2 and enhanced its tumor suppressor function
    Jong-Ryoul Choi, Seo-Young Lee, Ki Soon Shin, Cheol Yong Choi, Shin Jung Kang · 2017 · Scientific Reports
  83. Tauopathies: Mechanisms and Therapeutic Strategies
    Chen‐Chen Tan, Xiao-Yan Zhang, Lan Tan, Jin‐Tai Yu · 2017 · Journal of Alzheimer s Disease
  84. Sirt‐1 Regulates Physiological Process and Exerts Protective Effects against Oxidative Stress
    Lei Liu, Guangyuan Xia, Peifan Li, Yiming Wang, Qian Lei Zhao · 2021 · BioMed Research International
  85. Neuroprotection by resveratrol: A review on brain delivery strategies for Alzheimer's and Parkinson's disease
    Vasanthi Chinraj, R. Sureshkumar · 2022 · Journal of Applied Pharmaceutical Science
  86. Targets, trials and tribulations in Alzheimer therapeutics
    Ruchita Gharat, Gargi Dixit, Mihir Khambete, Arati Prabhu · 2023 · European Journal of Pharmacology
  87. Epigenetic modifications of DNA and RNA in Alzheimer’s disease
    Paula Martínez-Feduchi, Peng Jin, Bing Yao · 2024 · Frontiers in Molecular Neuroscience
  88. Clinical Trials: Past, Current, and Future for Atypical Parkinsonian Syndromes
    Adam L. Boxer, Richard M. Tsai · 2014 · Seminars in Neurology
  89. Acetylation of calmodulin regulates synaptic plasticity and fear learning
    Hailong Zhang, Bing Tian Zhao, Wei Han, Yi-Bei Sun, Pin Yang, Yongjun Chen, Duan Ni, Jian Zhang, Dong‐Min Yin · 2021 · Journal of Biological Chemistry
  90. Unraveling the Influence of K280 Acetylation on the Conformational Features of Tau Core Fragment: A Molecular Dynamics Simulation Study
    Yu Feng Zou, Lulu Guan · 2021 · Frontiers in Molecular Biosciences
  91. Pharmacological modulation of the PI3K/AKT/GSK3β axis: a new frontier in Alzheimer’s disease treatment
    Saad Misfer Alqahtani, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Ali K. Albuhadily, Mustafa M Shokr, Athanasios T. Alexiou, Marios Papadakis, Gaber El‐Saber Batiha · 2025 · Inflammopharmacology
  92. Pharmacologic reversal of advanced Alzheimer’s disease in mice and identification of potential therapeutic nodes in human brain
    Kalyani Chaubey, E. Vázquez-Rosa, S. Tripathi, Min-Kyoo Shin, Young Jun Yu, Matasha Dhar, Suwarna Chakraborty, Mai Yamakawa, Xin-Ming Wang, Preethy S. Sridharan et al. · 2025 · Cell Reports Medicine
  93. Research progresses on flavonoids isolated from traditional Chinese medicine in treatment of Alzheimer's disease
    Gao · 2013 · Intractable & Rare Diseases Research
  94. Dementia Therapy Targeting Tau
    Luc Buée · 2019 · Advances in experimental medicine and biology
  95. Virtual Screening in the Identification of Sirtuins’ Activity Modulators
    Elena Abbotto, Naomi Scarano, Francesco Piacente, Enrico Millo, Elena Cichero, Santina Bruzzone · 2022 · Molecules
  96. Sleep, Sirtuin 1 and Alzheimer’s disease: A review
    Mehrane Mehramiz, Tenielle Porter, Simon Matthew Laws, Stephanie Ruth Rainey‐Smith · 2022 · Aging Brain
  97. Acetylation and phosphorylation processes modulate Tau’s binding to microtubules: A molecular dynamics study
    Tarsila G. Castro, Tiago Ferreira, Teresa Matamá, Florentina‐Daniela Munteanu, Artur Manuel Cavaco-Paulo · 2022 · Biochimica et Biophysica Acta (BBA) - General Subjects
  98. Chaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapy
    Yi Liu, Ming Tan, Meng‐Shan Tan · 2023 · Molecular and Cellular Biochemistry
  99. 14-3-3ζ Participates in the Phase Separation of Phosphorylated and Glycated Tau and Modulates the Physiological and Pathological Functions of Tau
    Yuqing Liu, Chu-Qiao Liang, Zhiwei Chen, Jun Hu, Jin‐Jian Hu, Yun-Yi Luo, Yong‐Xiang Chen, Yanmei Li · 2023 · ACS Chemical Neuroscience
  100. Molecular mechanisms implicated in protein changes in the Alzheimer’s disease human hippocampus
    Hai Duc Nguyen, Woong-Ki Kim, Giang Huong Vu · 2024 · Mechanisms of Ageing and Development